1. Home
  2. ZLAB vs ATEX Comparison

ZLAB vs ATEX Comparison

Compare ZLAB & ATEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$19.77

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Logo Anterix Inc.

ATEX

Anterix Inc.

HOLD

Current Price

$103.50

Market Cap

2.0B

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZLAB
ATEX
Founded
2013
1997
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.0B
IPO Year
2017
2014

Fundamental Metrics

Financial Performance
Metric
ZLAB
ATEX
Price
$19.77
$103.50
Analyst Decision
Strong Buy
Buy
Analyst Count
5
1
Target Price
$49.60
$50.00
AVG Volume (30 Days)
888.8K
635.1K
Earning Date
05-07-2026
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
38.46
891.80
EPS
N/A
4.83
Revenue
$460,156,000.00
$6,501,000.00
Revenue This Year
$9.75
$2.70
Revenue Next Year
$26.03
$10.04
P/E Ratio
N/A
$20.89
Revenue Growth
15.33
7.79
52 Week Low
$15.96
$17.58
52 Week High
$41.20
$111.90

Technical Indicators

Market Signals
Indicator
ZLAB
ATEX
Relative Strength Index (RSI) 62.65 72.55
Support Level $19.51 $21.01
Resistance Level $20.25 N/A
Average True Range (ATR) 0.75 7.43
MACD 0.24 1.32
Stochastic Oscillator 99.24 81.10

Price Performance

Historical Comparison
ZLAB
ATEX

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About ATEX Anterix Inc.

Anterix Inc is the holder of licensed 900 MHz spectrum (896-901/935-940 MHz) with coverage spanning the contiguous United States, Hawaii, Alaska, and Puerto Rico. The Company is focused on commercializing its spectrum assets and delivering intelligent infrastructure solutions, including private broadband networks, tower access, and turnkey connectivity management, to utility and critical infrastructure enterprises. It provides mission-critical private 900 MHz spectrum to the utility sector and integrated deployment solutions that support a secure, resilient, and decarbonized future. Its solutions include 900 MHz Private Wireless, TowerX, and CatalyX.

Share on Social Networks: